Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 3, 1999, Pages 537-542

  Sun, Zhonghe ^a   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; NICOTINAMIDASE; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ARTICLE; ENZYME ACTIVITY; GENE MUTATION; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TUBERCULOSIS;

EID: 0033052157     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.3.537     Document Type: Article

References (27)

1. Cynamon, M. H., R. Gimi, F. Gyenes, C. A. Sharpe, K. E. Bergermann, H. J. Han, L. B. Gregor, R. Rapolu, G. Luciano, and J. T. Welch. 1995. Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity. J. Med. Chem. 38:3902-3907.
2. Foster, J. W., and A. G. Moat. 1980. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol. Rev. 44:83-105.
3. Garbe, T., J. Barathi, S. Barnini, Y. Zhang, C. Abou-Zeid, D. Tang, R. Mukherjee, and D. Young. 1994. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133-138.
4. Good, R. C., V. A. Silcox, J. O. Kilburn, and B. D. Plikaytis. 1985. Identification and drug susceptibility test results for Mycobacterium spp. Clin. Microbiol. Newslett. 7:133-136.
5. Helbecque, D. M., V. Handzel, and L. Eidus. 1975. Simple amidase test for identification of mycobacteria. J. Clin. Microbiol. 1:50-53.
6. Inderlied, C. B., and K. A. Nash. 1996. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanism of action and resistance, and assays for activity in biological fluids, p. 127-175. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
7. Jarlier, V., and H. Nikaido. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123:11-18.
8. Konno, K., F. M. Feldman, and W. McDermott. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95:461-469.
9. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity in Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20: 556-557.
10. McDermott, W., and R. Tompsett. 1954. Activation of pyrazinamide and nicotinamide in acidic environment in vitro. Am. Rev. Tuberc. 70:748-754.
11. Miller, M. A., L. Thibert, F. Desjardins, S. H. Siddiqi, and A. Dascal. 1995. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J. Clin. Microbiol. 33: 2468-2470.
12. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
13. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
14. Scorpio, A., D. Collins, D. Whipple, D. Cave, J. Bates, and Y. Zhang. 1997. Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. J. Clin. Microbiol. 35: 106-110.
15. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
16. Speirs, R. J., J. T. Welch, and M. H. Cynamon. 1995. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacteriurn tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide. Antimicrob. Agents Chemother. 39:1269-1271.
17. Sreevatsan, S., X. Pan, Y. Zhang, B. N. Kreiswirth, and J. M. Musser. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41: 636-640.
18. Sun, Z. H., A. Scorpio, and Y. Zhang. 1997. The pncA gene from the naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. Microbiology 143:3367-3373.
19. Tanigawa, Y., M. Shimoyama, and I. Ueda. 1980. Nicotinamide deamidase from Flavobacterium peregrinum. Methods Enzymol. 66:132-136.
20. Tarnok, I., and E. Rohrscheidt. 1976. Biochemical background of some enzymatic tests used for the differentiation of mycobacteria. Tubercle 57: 145-150.
21. Tarshis, M. S., and W. A. Weed. 1953. Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am. Rev. Tuberc. 67:391-395.
22. Trivedi, S. S., and S. G. Desai. 1987. Pyrazinamidase activity of Mycobacterium tuberculosis - a test of sensitivity to pyrazinamide. Tubercle 68:221-224.
23. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
24. Witzig, R. S., B. A. Fazal, R. M. Mera, D. M. Mushatt, P. M. Dejace, D. L. Greer, and N. E. Hyslop. 1995. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin. Infect. Dis. 21:77-85.
25. Zhang, Y., M. J. Garcia, R. Lathigra, B. Allen, C. Moreno, J. D. A. van Embden, and D. Young. 1992. Alterations in the superoxide dismutase gene of an isoniazid-resistant strain of Mycobacterium tuberculosis. Infect. Immun. 60:2160-2165.
26. Zhang, Y., T. Garbe, and D. Young. 1993. Transformation with katG restores isoniazid sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:521-524.
27. Zhang, Y., A. Scorpio, H. Nikaido, and Z. Sun. Role of acid pH and deficient efflux of pyrazinoic acid in the unique susceptibility of Mycobacterium tuberculosis to the front-line tuberculosis drug pyrazinamide. Submitted for publication.